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Summary 
The induction of immunoglobulin E (IgE) switching in B cells requires at least two signals. 
The first is given by either of the soluble lymphokines interleukin 4 (IL-4) or IL-13, whereas 
the second is contact dependent. It has been widely reported that a second signal can be provided 
by the CD40 ligand (CD40L) expressed on the surface of T  cells, mast cells, and basophils.  A 
defect in the CD40L has been shown recently to be responsible for the lack of IgE, IgA, and 
IgG, characteristic of the childhood X-linked immunodeficiency, hyper IgM syndrome (HIGM1). 
IgE can however be detected in the serum of some HIGM1 patients. In this study, we isolated 
T  cell clones and lines using phytohemagglutinin (PHA) and allergen, respectively, from the 
peripheral blood of one such patient who expressed a truncated form of CD40L, and investigated 
their  ability  to  induce  IgE  switching  in  highly purified,  normal  tonsillar  B  cells  in  vitro. 
Unexpectedly, 4 of 12 PHA clones tested induced contact-dependent IgE synthesis in the presence 
of exogenous IL-4. These clones were also shown to strongly upregulate IL-4-induced germline 
e RNA and formed dense aggregates with B cells. Of the four helper clones, three were CD8 +, 
of which two were characteristic of the T  helper cell 2 (Th2)  subtype. Two allergen-specific 
HIGM1 T cell lines, both of the Th0 subtype, could also drive IgE synthesis when prestimulated 
using specific allergen. All clones and lines were negative for surface expression of CD40L, and 
the mutated form of CD40L was confirmed for a representative clone by RNase protection assay 
and sequencing. The IgE helper activity could not be attributed to membrane tumor necrosis 
factor c~ (TNF-a) although it was strongly expressed on activated clones, and the addition of 
neutralizing anti-TNF-c~ antibody did not abrogate IgE synthesis. These results therefore suggest 
the involvement of T cell surface molecules other than CD40L in the induction of IgE synthesis, 
and that these molecules may also be implicated in other aspects  of T-B cell interactions. 
2•ctivated 
T cells induce IgE switching in B cells via a com- 
bination  of lymphokines and direct T-B cell contact 
(1-6). One of the T cell surface structures considered to play 
a central role in upregulating lymphokine-triggered germ- 
line e transcript synthesis via CD40 on B cells is the CD40 
ligand  (CD40L) 1,  a  type  II  membrane protein  with  ho- 
mology to TNF-c~ and -~3 (7, 8, and for a review see refer- 
ence 9). In X-linked hyper IgM syndrome (HIGM1), a child- 
hood immunodeficiency, there are greatly decreased serum 
levels of IgG, IgA, and IgE, with normal to increased levels 
1  Abbreviations used in this  paper: CD40L, CD40 ligand; EB-LCL, Epstein- 
Barr virus-transformed  lymphoblastoid cell line; HIGM1, hyper IgM 
syndrome. 
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of IgM and IgD (for a review see reference 10). This defect 
in Ig isotype switching has been attributed to a lack of func- 
tional CD40L expression on T  cells, resulting from either 
deletions or point mutations within a limited region of the 
CD40L extracellular domain (11-14). Given that serum IgE 
is still detectable in some HIGM1 patients, we wished to know 
whether T cell clones isolated from such a patient could in- 
duce IgE synthesis in vitro. Here we report that mitogen- 
stimulated T cell clones and allergen-stimulated T cell lines 
isolated from PBMC  of a HIGM1  patient are able,  in the 
presence of IL-4, to induce contact-dependent IgE synthesis 
by pure tonsillar B cells,  despite the total absence of func- 
tional CD40L.  The HIGM1 T  cell help for IgE synthesis 
cannot be wholly accounted for by membrane TNF-ot. This 
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Volume 180  November  1994  1775-1784 suggests  that  other  T  cell  surface molecule(s),  in  addition 
to CD40L are able to induce IgE synthesis and may explain 
why  IgE can  still be detected  in  some  HIGM1  patients. 
Materials and Methods 
Patient 
Patient MAB, a 9-yr-old boy, had a family history of X-linked 
immunodeficiency, and presented with clinical features of HIGM1 
at 3 yr of age.  A  10-bp  deletion in his CD40L gene produces a 
premature stop codon at AA144, thus causing a large ddetion in 
the extracellular domain of CD40L (patient no. 4 in reference  11). 
At the commencement of study, his total serum IgE titer was 1 
ng/ml.  Prior testing of PBMC-proliferative responses  to a panel 
of mitogens, recall antigens,  and allergens showed vigorous responses 
to PHA and to a dog hair allergen hyposensitization vaccine (data 
not  shown). 
T  Cell Clones 
PBMC  were  separated from heparinized  venous blood using 
Ficoll-Hypaque and stimulated for 7 d with either 1 #g/ml PHA 
(HA-16;  Wellcome, Beckenham,  UK) or 10/ig/ml dog hair al- 
lergen, Alyostal ST-IR (Stallergenes,  Paris, France),  and 200 U/ml 
human recombinant IL-4 (Amersham International,  Amersham, 
Bucks,  UK). Prestimulation and cloning of PBMC was done in 
IMDM (Gibco, Paisley, Scotland) supplemented with  10% heat- 
inactivated  AB §  human  serum  (Centre  Transfusion  Sanguine, 
Annemasse,  France),  2 mM glutamine  (Flow,  Irvine, Scotland), 
100/xg/ml streptomycin, 100 U/m1 penicillin (Gibco), 1% non- 
essential  amino acids, 1% sodium pyruvate, and 1 mM Hepes (all 
from Sigma Chemical Co., St. Louis, MO), complete medium. T 
cells blasts were cloned by limiting dilution in 20 #1 Terasaki wells 
(Nunc,  Roskilde,  Denmark)  using  autologous  y-irradiated 
mononuclear  cells  (104), 100  U/ml  human  recombinant  IL-2 
(Glaxo Institute), and 1 #g/ml PHA or 10/~g/ml dog hair allergen. 
Growing colonies were transferred to 200/zl  U-bottomed wells 
(Nunc) at day 11  and restimulated with  5  x  104 irradiated,  al- 
logeneic PBMC,  1 /zg/ml PHA,  100 U/ml IL-2, and 200  U/ml 
ILo4 in CM.  Expansion  was continued by twice weekly feeding 
with  IL-2 and IL-4 and by restimulation every 14-21 d  with al- 
logeneic PBMC and PHA.  Clones were only used in IgE assays 
at least  14 d  after restimulation. 
Immunoglobulin Assays 
B Lymphocyte Separation.  B lymphocytes were isolated from 
Ficoll-separated  tonsillar mononuclear cells by a two-step negative 
selection  procedure using sheep cell rosetting and magnetic bead 
depletion (Dynal, Norway) to remove T  cells. B cell purity was 
routinely >99% as determined by FACS  |  Cells were resuspended 
at  106 cells/ml in IMDM enriched  as described previously (15). 
Percoll was used to isolate high density (resting) and low density 
(activated)  B cells. Briefly,  tonsillar B cells purified as above were 
layered onto a 65% and 60% Percoll  gradient (Pharmacia, Upp- 
sala, Sweden) and centrifuged at 2,100  rpm for 20  rain at 4~ 
High and low density cells were collected,  washed and resuspended 
as described above. 
Prestimulation ofT Cell Clones.  7.5  x  105 T cells were cocul- 
tured in 2-ml wells  (Falcon,  Oxnard,  CA) with 5  x  105 y-irra- 
diated (3,500 rad) PBMC and 0.1 #g/ml PHA in CM for 6 d. In 
some experiments, T cells were stimulated with PHA or dog hair 
allergen in the presence of an autologous Epstein Barr virus-trans- 
formed lymphoblastoid cell line (MAB EB-LCL). EB-LCL were 
irradiated with 6,000  rad and added to T  cells at 3  x  105 cells 
per well.  Stimulated T  cells were washed three times in PBS to 
remove human serum before resuspension  in Yssel's medium at 106 
cells/ml.  Prestimulated T cells (10  s) were cocultured with tonsillar 
B cells (105) in Yssel's medium supplemented with 200 U/ml rlL-4 
for 14 d.  Supernatants were tested for IgE/IgG by ELISA (16). 
To investigate the contact dependency of T cell help for IgE in- 
duction,  5  x  105 T  cells,  prestimulated as described above were 
incubated with 5  x  10  s tonsillar B cells and 200  U/ml in 2 ml 
Transwells  (Costar, Cambridge, MA) with a membrane pore di- 
ameter of 0.4/xm. Supernatants were taken from the B cell-con- 
taining chamber after 14-d culture and assayed for IgE as described 
above. 
To test if T  cell clones could upregulate germline e transcrip- 
tion, 106 T cells, preactivated using auto-EB-LCL and PHA were 
cocultured with an equal number of tonsillar B ceils and 200 U/ml 
rIL-4 for 5 d  in duplicate 2-ml wells  (Falcon). 
Northern Blot Assays 
Total RNA was isolated by extraction  with RNAzol (Cinna/Bio- 
teck Laboratories, Houston, TX) according to the manufacturer's 
instructions. Aliquots of RNA corresponding to one third of the 
isolated RNA were subjected to denaturing agarose electropho- 
resis, transferred to nylon + membrane, and fixed by UV irradia- 
tion as described previously (17). Hybridizations with cRNA probes 
complementary to Ce or to actin mRNA were performed as de- 
scribed  previously (17). 
Measurement of T  Cell Cytoteines 
106 T  cells were cocultured for 24 h  with Con A  (10/ig/ml, 
Sigma). Culture supernatants were filtered (0.22  #m) and tested 
for II.-2, IL-4, and IFN-y (Glaxo Institute) using ELISA kits (Gen- 
zyme, Cambridge,  MA). 
Immunostaining 
Surface phenotyping of clones was performed by staining with 
specific antibodies and flow cytometry as described  previously (8). 
Antibodies used were leu 4-FITC, leu 3a +  3b-FITC, leu 2a, anti- 
TCR-oz//3, anti-TCR-y/& CD3-PE, mouse IgG1 pure, and FITC- 
labeled and mouse IgG2a pure, all purchased from Becton Dick- 
inson & Co. (Mountain View, CA). Goat anti-mouse FITC was 
purchased from Bioart (Nanterre, France).  Polyclonal  rabbit anti- 
TNF-oz (MCA255; Serotec, Oxford, UK) was revealed using anti- 
rabbit IgGI(ab')2-FITC (Caltag Laboratories, San Francisco,  CA). 
T Cell Surface Expression of CD40L 
106 T  cells were cocultured  with  10 ng/ml PMA and  1 /~M 
ionomycin (both from Calbiochem-Novabiochem Corp., La Jolla, 
CA) for 5 h and stained for expression of CD40L using CD40Fc 
and fluorescein-labeled  goat anti-mouse IgG2a as described previ- 
ously (8). 
Analysis of CD40L RNA  by RNase Protection Assay 
An RNA probe complementary to the deleted region of CD40L 
was generated by PCR  amplification of nucleotides  386-603  of 
CD40L cDNA using the primers CGATGAATTCGTGATCAG- 
AATCCTCAAATTGC  and  CTAGGAATTCTGGAGCTTGAC- 
TCGAAGCTTCC (8).  The cDNA fragment was cloned in the 
EcoRI  site  of pBluescript  IISK-  (Stratagene,  La Jolla,  CA).  A 
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scription  in  the  presence of [32p]UTP (400 Ci/Mmol)  of the 
pBluescript IISK- template linearized with BamHI.  Full-length 
probe was purified by acrylamide-urea  gel electrophoresis. Aliquots 
of eluted probe (5  x  105 cpm) were coprecipitated with 50 #g 
of total RNA isolated from T cell clones JF7 (8), MAB PHA .3.6, 
and 20/xg tRNA or tRNA alone. The RNase protection  assay 
was performed using a kit (Boehringer Mannheim,  Mannheim, 
Germany) according to the manufacturer's instructions. 
Analysis of  the CD40L cDNA Sequence  for T Cell Clone  MAB 
PHA .3.6 
Poly (A) + RNA was subjected to oligo dT primed reverse  tran- 
scription, cDNA was amplified  by PCR using the primers described 
above and cloned in the EcoRI site of pBluescript IISK-. The 
DNA sequence was determined by the dideoxy method (18). 
Results 
Induction of lgE Synthesis by HIGM1  T Cell Clones and Lines 
T cell outgrowth was seen in 30 out of a total of 300 PHA- 
stimulated wells.  12 of these T  cell colonies, derived from 
wells seeded with 0.3-100 PHA-stimulated T cell blasts were 
expanded and tested for their ability to induce IgE synthesis 
in very highly purified (>99%) tonsillar B cells. In the first 
assay, T  cells were prestimulated with PHA and irradiated 
aUo-PBMC 5 d before coculture with B cells. Unexpectedly, 
two T cell clones (1.14 and .3.6) induced measurable IgE syn- 
thesis which was dependent on the presence of exogenous 
IL-4. No IgE was detected in cultures containing B cells with 
IL-4 alone (Fig.  1 A). The levels oflgG measured in the same 
cultures varied among clones. For example, clone MAB PHA 
.3.6 markedly increased IgG production over the anti-CD40 
mAb background, whereas clone MAB  1.14 did not (Fig. 
1 A). It is interesting to note that dense cellular aggregates 
were seen only in cultures found later to contain IgE. 
To exclude the possibility that the T cell stimulus for IgE 
switching might have been provided by the irradiated PBMC 
used for prestimulation, the IgE helper clones were retested 
after prestimulation with irradiated autologous EB-LCL and 
PHA. Tonsillar B cells cultured with these EB-LCL preacti- 
vated T cell clones and exogenous IL-4 were still able to pro- 
duce IgE. No IgE was detected in cultures of B cells alone, 
nor in B cells cultured with the irradiated EB-LCL used for 
T cell prestimulation. During this assay, a further two PHA 
clones (MAB PHA .3.3 and .3.4) were identified as able to 
induce IgE  synthesis  (Fig.  1 B). 
To ensure that the IgE measured was not simply the product 
of IgE precommitted cells, an assay was done as above using 
high density (resting) Percoll-fractionated tonsillar B cells. 
Again, IgE was detectable in B cell cultures containing HIGM1 
T  cell clones, but not in cultures of B cells and IL-4 alone 
(data not shown). 
Fig.  1 B  also  shows  data  for two  dog  allergen-specific 
HIGM1 T cell lines (MAB DOG 5.2 and 5.5) which induced 
IgE synthesis when prestimulated using dog allergen and au- 
tologous, irradiated EB-LCL as APC. A CD40L-positive, dog 
aUergen-specific T cell clone, OZZ .3.4, isolated from a normal 
Figure  1.  Induction  of immunoglobulin synthesis by HIGM1 T cell 
clones and lines. 10  s preactivated  T cells  were coincubated  with 105 ton- 
sillar B cells for 14 d in the presence of human recombinant IL-4 (200 
U/ml). Culture  supernatants were  tested  for IgE and IgG by specific  ELISA 
as described  in Materials and Methods. As a positive  control, anti-CD40 
mAb was used at 1 #g/ml. (A) IgE and IgG production  by tonsillar B 
cells (>99% pure) driven by T cell clones from HIGM1 patient MAB, 
prestimulated  for 6 d using  allogeneic,  irradiated  PBMC and PHA (1/~g/ml). 
(B) Similar assay, except  that the T cell clones were prestimulated  with 
autologous, irradiated  EB-LCL  and PHA (or dog allergen  in the case of 
MAB DOG lines) for 6 d before  addition to B cells (>98% pure). Also 
shown is wild-type  clone  OZZ.3.4, prestimulated  using PHA and autolo- 
gous EB-LCL. 
donor (Life, R, V. Schnuriger, S. Estoppey, G. Mazzei, and 
J.-Y. Bonnefoy, manuscript in preparation), was included in 
this  assay as a second positive IgE control. 
With the exception of T  cell line MAB DOG 5.2,  the 
levels of IgE produced in the HIGM1 T cell-driven cultures 
were markedly lower than those in cultures containing ei- 
ther anti-CD40 mAb  or the wild-type clone (Fig.  1 B). 
As described above, dense cellular aggregates were seen in 
IgE-positive cultures. FACS  |  analysis (Becton Dickinson & 
Co.) showed the aggregates to consist of T  and B cells in 
varying proportions (data not shown). The tendency for dense 
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gested that the help for IgE synthesis was contact mediated. 
This  was confirmed using  a  Transwell  system in  which  T 
cells  were separated from highly purified tonsillar B cells  by 
a  semi-permeable  membrane  of 0.4-#m  pore  size.  Both 
chambers contained 200  U/ml of rlL-4.  The data in Table 
1 clearly demonstrate the contact dependancy of the T-B cell 
interaction in that no IgE was detected when T-B cell con- 
tact was interrupted. Also, dense cellular aggregates were again 
seen in mixed T-B cultures,  but were absent when the cell 
types were  separated  by a  semi-permeable  membrane. 
To examine whether  IgE nonhelper clones either express 
or secrete factors able  to  suppress  IgE synthesis,  two  such 
clones were prestimulated using PHA and coincubated with 
B  cells,  IL-4,  and  anti-CD40  mAb  at  a concentration  op- 
timal for induction of IgE synthesis.  Fig.  2  shows that the 
presence of nonhelper T  cells  did not suppress IgE produc- 
tion. In the same experiment, the addition of anti-CD40 mAb 
to an IgE helper T  cell clone isolated from a normal donor 
produced a marked synergistic effect on IgE synthesis (Fig. 2). 
Upregulation of Germline  e  RNA  by HIGMI  T  Cell  Clones 
Having shown that HIGM1 clones could induce IgE syn- 
thesis,  we examined if induction  of IgE synthesis by these 
clones was also preceded by upregulation of germline E RNA. 
Northern blot analysis of germline ~ t<NA levels  indicated 
that wild-type T  cell clones from two donors and CD40L- 
deficient T  cell clones activated to make them competent to 
induce IgE synthesis  in  the presence of IL-4 similarly up- 
regulated  germline  6 RNA.  Importantly,  no upregulation 
of germline  6 RNA  was observed with  the irradiated  EB- 
LCL used  to prestimulate  the  clones  (Fig.  3). 
Phenotype and Lyrnphokine Profile of  lgE Helper HIGMI  T  Cell 
Clones  and Lines 
T  cell clones able to induce IgE synthesis were analysed 
using a FACS  |  (Becton Dickinson & Co.) for surface expres- 
sion of a range ofT cell surface markers. The results are sum- 
marized in  Table 2.  Three of the four clones were CD8 +, 
the other was CD4 §  All clones expressed  both CD3  and 
Table  1.  Contact-dependent  HIGMI  T  Cell Help for IgE Synthesis 
ng/ml 
B  -  IL-4  <0.2 
B  +  IL-4  <0.2 
B  +  IL-4  +  anti-CD40 mAb  100  _+  15 
B  +  IL-4 MAB PHA  1.14  (contact  +)  11  _+  4 
B  +  IL-4  +  MAB PHA  1.14  (contact  -)  <0.2 
5  x  10  s tonsillar B cells (>99% pure) were coincubated with an equal 
number of PHA-prestimulated HIGM1 T cell clones (MAB PHA 1.14) 
in 2-ml culture wells either mixed (contact + ) or separated by a semi- 
permeable membrane (contact -  ). IgE was measured by ELISA  at day 14. 
B+IL-4~ 
B+IL-4 + MAB PHA 1.1 ~-~  I 
B+IL-4 + MAB PHA 1.4~ 
t-..',.\'..',.',.'~j  ' 
OZZ  3 4 ~  +  .. 
I 
r  i  i  i  i  i 
0  50  100  150  200  250  300  350 
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I=-CD4OMabJ~+  CD4OMab  { 
Figure  2.  Effect  of HIGM1 and normal T cell clones on anti-CD40- 
driven IgE synthesis. 105 tonsillar B cells (>99% pure) were cocultured 
with  105 T cell clone for 14 d either in the presence or absence of anti- 
CD40 mAb (1/zg/ml). IgE production was measured by specific  ELISA. 
Data are shown for two HIGM1 clones (MAB PHA 1.1 and 1.4) which 
reproducibly fail to induce IgE synthesis, and a clone isolated from a non- 
HIGM1 donor (OZZ .3.4), able to induce IgE. All clones were prestimu- 
lated for 6 d using allogeneic, irradiated PBMC and PHA (1 #g/ml) before 
addition to B cells. All cultures contained 200 U/ml rlL-4. 
Figure  3.  Wild-type and CD40L deficient T cell clones trigger germ- 
line e RNA synthesis. Cells were incubated for 5 d with IL-4  (200 U/ml) 
as described in Materials and Methods. Lane  1, tonsillar B cells alone; lane 
2, B cells stimulated with anti-CD40 mAb (1 #g/ml); lane 3, wild-type 
T cell clone OZZ .3.4 alone; lane 4, clone OZZ .3.4 and B ceils; lane 
5, wild-type T cell clone TT7 alone; lane 6, clone TT7 and B cells; lane 
7, HIGM1 T cell clone MAB PHA .3.6 alone; lane 8, clone MAB PHA 
.3.6 and B cells; lane 9, HIGM1 T cell clone MAB PHA 1.14 alone; lane 
I0, clone MAB PHA 1.14 and B cells; lane 11, HIGM1 T cell clone MAB 
PHA .3.4 alone; lane 12, clone MAB PHA .3.4 and B cells; lane 13, irradi- 
ated EBV-transformed B cell line MAB-EB alone; and lane 14, MAB-EB 
and B cells. Aliquots of RNA representing one third of RNA isolated 
from the cultures were analyzed by Northern blot with cRNA probes 
specific for C6 or actin mRNA. Cultures included 106 of the following 
cell types: T cell clones; purified tonsillar B cells; and irradiated EBV- 
transformed B cells. 
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Clone  CD3  CD4  CD8  TCR-ot/~  TCR-y/5  IL-2  IL-4  IFN-y 
MAB  pg/ml 
.3.3  +  -  +  +  -  0  85  0 
.3.4  +  -  +  +  -  975  2,055  0 
.3.6  +  +  -  +  -  0  1,700  0 
1.14  +  -  +  +  -  0  1,075  0 
5.2  +  80%  20%  +  -  0  850  125 
5.5  +  75%  25%  +  -  0  210  0 




+  +  -  +  -  0  1,640  0 
T cell clones and lines were stained for the surface markers shown using standard techniques and FACS  |  analysis. The mAbs used are described 
in Materials and Methods. Cells were phenotyped  at least 14 d after stimulation with PHA and allogeneic  PBMC. To determine  lymphokine  produc- 
tion, 106 cells were stimulated with Con A (10 #g/ml) for 24 h and supernatants were tested using specific ELISA kits. IgE helper T cell clones 
OZZ .3.4 and POD 5.9 are from two normal donors. 
a TCR-ot/~. The dog allergen-specific T cell lines contained 
both CD4 ~ and CD8 § cells. To determine the lymphokine 
profile of the IgE helper T  cell clones and lines,  each was 
stimulated with an optimal concentration of Con A for 24 h 
and supernatants were tested for IL-2, IL-4, and IFN-'y by 
ELISA. Data are given in Table 2. Three clones (MAB PHA 
.3.3,  .3.6,  and  1.14) secreted IL-4 only whereas the other 
(MAB PHA .3.4) secreted both IL-4 and IL-2. Of the two 
dog allergen-specific HIGM1 lines,  one (MAB DOG 5.5) 
secreted IL-4 only whereas the other (MAB DOG 5.2) secreted 
both IL-4 and IFN-% Also shown in Table 2 are the surface 
phenotype and lymphokine profile of two wild-type IgE helper 
T cell clones used in this study. Clone POD 5.9 secretes only 
IL-4 in similar amounts to HIGM1 clone MAB PHA .3.6 
but considerably more than MAB PHA 1.14 and .3.3. In con- 
trast, clone OZZ .3.4 secretes both IL-4 and IFN-% yet is 
a potent and reproducible inducer of IgE synthesis (Fig. 1 B 
and Life, P.  F., unpublished data). Taking these two wild- 
type clones as representative examples, there was clearly no 
major difference in  IL-4 secretion between  these  and  the 
HIGM1 helper clones. 
CD40L Expression in HIGM1  T  Cell Clones 
In view of the unexpected ability of HIGM1 T cell clones 
to induce IgE synthesis, three approaches were taken to confirm 
that the clones did indeed express the mutated form of CD40L. 
This was intended also to exclude the unlikely possibility that 
wild-type CD40L from irradiated feeders could have contami- 
nated the clones. 
Cell Surface Expression.  MAB T cell clones and lines were 
stimulated under optimal conditions using PMA and iono- 
mycin and examined for surface expression of CD40L using 
CD40Fc and a FACS  |  as described in Materials and Methods. 
Each of the four clones and two lines were negative. As a 
positive control, T cell clones isolated from two normal donors 
stained strongly positive for CD40L in the same experiment 
(Fig.  4). 
Analysis of CD40L mRNA by RNase Protection.  An RNase 
protection assay was used to differentiate between wild-type 
and mutated CD40L mKNA. The RNA probe used was com- 
plementary to 218 bases of CD40L RNA and was expected 
to give a mismatch when hybridized with mutated CD40L 
mRNA from the HIGM1 patient (patient no. 4; reference 
11). When hybridization was performed using wild-type RNA 
from T cell cloneJF7, stimulated for 4 h with PMA (10 ng/ml) 
and ionomycin (1/zM), a major band of 0.2 kb was observed 
by polyacrylamide-urea gel autoradiography after RNase pro- 
tection assay. This band was replaced by one of 0.1 kb using 
KNA isolated from clone MAB PHA .3.6 activated under 
identical conditions (data not shown).  This indicated that 
the hybrid contained the expected deletion mismatch. 
Isolation and Sequencing of Mutated CD40L from  T  Cell 
Clones.  To  show directly that  the CD40L was  mutated, 
mRNA was isolated and reverse transcribed from an IgE helper 
HIGM1 T  cell clone (MAB PHA  .3.6). A region flanking 
the expected mutation was  amplified using PCR  and  the 
product cloned in pBluescript. Five independent cDNA in- 
serts were characterized. As expected, each clone contained 
the 10-bp deletion, confirming that clone MAB PHA  .3.6 
expressed the mutated form of CD40I, as described previ- 
ously (11). 
Cell Surface Expression of Membrane TNF-oe and IgE Blocking 
Assays  Using Anti-TNF-oe 
Having confirmed the absence of functional CD40L in the 
IgE helper HIGM1 T cell clones, we then investigated whether 
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Figure 4.  Lack of CD40L surface expression of HIGM1 T cell clones 
and lines. IgE-helper HIGM1 clones (MAB PHA .3.4,  .3.6, .3.3, and 1.t4) 
were stimulated for 5 h using optimal concentrations of PMA and ionomycin 
and analyzed by FACS  |  for expression of CD40L using CD40Fc and goat 
anti-mouse tgG2a-FITC as described in Materials and Methods. Two wild- 
type T cell clones from normal donors  (OZZ  .3.2 and POD 5.9) stained 
during the same experiment,  are shown as positive controls  for CD40L 
expression.  Histograms represent  data from 5,000  cellular events. 
the clones express membrane-bound TNF-c~, a molecule that 
has recently been implicated in Ig isotype switching (19, 20). 
HIGM1 T cell clones and a wild-type clone (OZZ .3.4) were 
stimulated using irradiated,  autologous EB-LCL and PHA 
and  stained  daily  for  TNF-c~  expression  as  described  in 
Materials and Methods.  FACS |  analyses  are shown in Fig. 
5.  For each clone there was a marked induction of TNF-c~ 
expression at day 2 which remained until day 8-9 of culture, 
depending on the clone studied. Neither unstimulated T cells 
nor irradiated EB-LCL stained positive for TNF-o~. The in- 
duction of TNF-c~ expression in these stimulated HIGM1 
clones was confirmed by Northern  blot analysis (data not 
shown). To investigate if membrane TNF-c~ was responsible 
for the observed HIGMl-induced IgE synthesis, PHA pre- 
stimulated HIGM1 and wild-type T  cell clones were cocul- 
tured with tonsillar B cells and IL-4 in the presence or ab- 
sence of a neutralizing,  polyclonal antibody to TNF-cz. Data 
are shown in Table 3.  Although  anti-TNF-o~ caused some 
reduction of IgE in the HIGM1 clone MAB .3.6,  this was 
not dose related and was not seen in the other HIGM1 clone 
(MAB PHA  1.14)  or wild-type clone. 
Discussion 
At least two cell-derived signals have been shown to be 
necessary for the induction of Ig isotype switching in B cells. 
The first signal is given by either of the soluble lymphokines 
IL-4 (1, 3) or IL-13 (6, for a review see reference 21) which 
induce germline e transcript  expression, but alone is insufficient 
to trigger  secretion of IgE. A  second signal is provided by 
a physical interaction between B cells and activated T  cells 
(2, 4, 5), basophils, and mast cells (22), and it has been shown 
in both  human  (23,  24)  and  murine  (7)  systems that  the 
CD40/CD40L pairing is able to mediate IgE synthesis.  In 
HIGM1, which is characterized by greatly decreased levels 
of IgG, IgA, and IgE (for a review see reference 10), there 
are mutations in the CD40L resulting in a completely non- 
functional extracellular domain (11-14).  Here we have been 
able to show that T cell clones and lines isolated from a HIGM1 
patient with very low, yet detectable serum IgE can in fact 
induce IgE synthesis despite expression of a truncated CD40L. 
T cell clones were made from PBMC using PHA and IL-4. 
The presence of IL-4 in a T cell blast population before cloning 
has been shown to increase the frequency of IL-4-secreting 
T cell clones (Th2) (25, and Life, P. L., unpublished observa- 
tions) and in the current study, four of the six clones tested 
were of the Th2  type. 
4 clones out of 12 tested were able to induce IgE synthesis 
by highly purified tonsillar B cells  (>99%  pure),  but only 
in the presence of exogenous IL-4.  There did not  seem to 
be a relationship between the ability of a clone to induce IgE 
and its ability to increase IgG synthesis. 
It is important  that neither IgE synthesis nor B cell pro- 
liferation  was  induced  in  IL-4-containing  cultures  where 
preactivated T cells were separated from B cells using a semi- 
permeable membrane. This demonstrated the contact depen- 
dency of the T cell-derived signals and excluded the possibility 
that  soluble factors were responsible for the observed IgE 
induction. 
It is interesting to note that three of the IgE helper clones 
were CD8 §  two of which were characteristic  of the Th2 
subtype. Generally,  CD8 ~ cells  have been associated with 
the  suppression  of IgE  and production  of Thl-type  lym- 
phokines (26, and for a review see reference 27). However, 
activated CD8 + cells can produce high levels of IL-4 (28-30) 
and  CD8 §  cells  have  been  shown  to  differentiate  into  a 
CD4-CD8-  phenotype that not only produces high levels 
of Th2 lymphokines but also drives IgE synthesis (31). How- 
ever, the CD8 + dories described in the present study did not 
lose CD8 expression. Moreover, CD8 + clones from allergic 
donors can trigger  IgE  synthesis (32) and express CD40L 
(8).  In the present  study however, CD40L was presumed, 
and later proven,  to be absent. 
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Figure  5.  Expression ofmembraneTNF-c~ onHIGM1TceUclones, lgE helper HIGM1T cell clones (MAB PHA .3.4, .3.6, and l.14)andawild-type 
clone (OZZ .3.4) were stimulated for 48 h using autologous, irradiated EB-I.CL and PHA (1 #g/ml) and analyzed for TNF-oe expression using a 
polyclonal rabbit anti-TNF-ce antibody and goat anti-rabbit IgG(ab')2-FITC as a second step. As a negative control, cells were stained using nonspecific 
rabbit IgG. Also shown are irradiated MAB and OZZ EB-LCL stained at the same time as the clones. FACS  |  histograms represent data from 5,000 
cellular events. 
Dog allergen-specific T  cell lines isolated from the same 
patient were also shown  to induce  IgE synthesis.  The two 
lines  studied  in detail  (MAB DOG  5.5  and  5.2)  were pre- 
dominantly  CD4 §  had  undetectable  surface CD40L,  and 
secreted IL-4 and IL-4/IFN-% respectively. These findings 
confirm and extend those using PHA-stimulated clones and 
suggest  possible physiological  relevance. 
HIGM1 clones were prestimulated for 6 d using a subop- 
timal dose of PHA in the presence of irradiated,  allogeneic 
PBMC before use in IgE assays.  This raised the concern as 
to whether activated T  cell membranes from PBMC might 
be responsible for the observed IgE synthesis.  We addressed 
this point by demonstrating  that HIGM1 clones could still 
trigger IgE synthesis if prestimulated using autologous EB- 
LCL,  negative for CD40L.  Although  the  autologous  EB- 
LCL were positive for CD23  (data not  shown),  known  to 
positively  regulate,  though  not  induce,  IgE  production 
through  CD21  ligation  (33,  34),  irradiated  EB-LCL alone 
plus IL-4 were,  as expected,  reproducibly unable to induce 
IgE synthesis in tonsillar B cells. Therefore, the co-signal for 
IgE synthesis must have been supplied by the HIGM1 clones 
and lines themselves. HIGM1 T  cell clones also induced IgE 
synthesis in high density tonsiUar B cells isolated using a Percoll 
gradient. These cells are considered resting (35) which argues 
strongly against IgE production from IgE precommitted or 
activated cells. 
IgE synthesis is preceded by transcription of the germline 
E RNA, and a relationship has been proposed between this 
expression and subsequent switching to Ce (36, 37). We were 
able to show  that HIGM1 T  cell clones and  IgE helper T 
cell clones that express wild-type CD40L did not differ overall 
in their ability to upregulated IL-4-induced germline e RNA 
Table  3.  Anti-TNF-cr Antibody Does Not Abrogate  HIGMI  T  Cell Help for IgE Synthesis 
MAB  PHA  1.14 
Clone  OZZ  .3.4  MAB  PHA  .3.6  Assay 1  Assay 2 
IgE ng/ml 
B alone  <0.2  <0.2  <0.2  <0.2 
B  +  anti-CD40  110  _+  6  68  _+  10  295  _+  36  42  +  30 
T  +  B  64  _+  14  18.5  _+  5  11  _+  4  18  _+  4 
T  +  B  +  anti-TNF-c~ 
10 /~g/ml  60  _+  20  10  _+  3  15  +  6  15  _+  4 
1 /~g/ml  93  _+  18  8  +-  2  10  _+  2  14  _+  5 
T and B cells were cocultured for 14 d in the presence of 200 U/ml rlL-4 as described in the legend to Fig. 1. Rabbit anti-TNF-c~ (dialyzed overnight 
against PBS at 4~  before use) was present throughout  the assay and used at the concentrations indicated. Clone OZZ .3.4 is from a normal donor, 
clones MAB PHA .3.6 and MAB 1.14 are from the HIGM1 patient.  As a positive control in each assay, anti-CD40 mab was used at 1/lg/ml. 
Negative control wells contained B cells and IL-4. Cell supernatants were tested for IgE by specific ELISA. 
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HIGM1 clone-driven cultures were less than those seen using 
wild-type clones or anti-CD40  mAb. 
Taken together, these findings suggested that a molecule(s) 
other than CD40L on the HIGM1 clones can upregulate IL- 
4-induced germline e mRNA expression and synthesis of 
mature IgE. 
Three approaches were taken to ensure that the observed 
IgE helper activity could not be attributed to contaminating 
wild-type CD40L  from irradiated allogeneic PBMC  used 
during routine cell expansion. First, CD40L was undetect- 
able on IgE helper HIGM1 clones, stimulated under condi- 
tions optimal for CD40L surface expression. Furthermore, 
more stringent analysis of an IgE helper HIGM1 clone (MAB 
PHA.3.6) by RNase protection assay and molecular cloning 
and sequencing confirmed the presence of the mutated form 
of CD40L. 
If CD40L is nonfunctional in the HIGM1 clones, then what 
is the nature of the T cell surface molecule(s) able to trigger 
IgE synthesis? Factors other than CD40L such as EBV and 
hydrocortisone are able to induce Ig isotype switching in the 
presence of IL-4 (38,  39). Also,  we (Fig.  2) and others (40, 
and Henchoz, S., unpublished observations) have shown that 
anti-CD40 mAbs synergize with T  cell clones to increase 
Ig switching, suggesting that CD40L is not the only T cell 
structure able to drive this response. It has been shown recently 
that  membrane TNF-ot,  expressed on activated CD4 §  T 
cells, can provide a costimulatory signal for IL-4-induced Ig 
production (19) even when CD40L is undetectable (20).  In 
this study we showed that membrane TNF-oe could be in- 
duced on IgE helper HIGM1 and wild-type T  cell clones. 
However, we were unable to abrogate IgE synthesis using 
up to 10 #g/ml of neutralizing anti-TNF-ot polyclonal anti- 
body, present throughout the assay. In support of these nega- 
tive findings, we also observed that COS cells,  transiently 
transfected with full-length TNF-ot using the pCDLSRot296 
vector and expressing surface TNF-ol, induced tonsiUar B cells 
to proliferate, but not to secrete IgE in the presence of IL-4 
(Gauchat, J.-F.,  unpublished data). 
Additional support for a secondary mechanism of Ig iso- 
type switching is emerging from many sources. Very recently, 
Wen et al. (41) demonstrated high titers of T cell-dependent 
Ig isotypes, including IgE, in mice congenitally deficient in 
ot/~ T cells. IgE help was provided by IL-4-secreting ",//8 + 
T cells which did not express CD40L. Also, anergized human 
T  cell clones specific for Der pl allergen no longer induced 
IgE synthesis in the presence of IL-4 despite expression of 
CD40L  (42).  Indirect support  for a secondary mechanism 
of Ig isotype switching comes from the unexpected finding 
that an anti-CD40L mAb did not alter the concentration of 
total IgG in mice immunized with collagen (43). 
An interesting observation from our study was the ten- 
dency for IgE helper HIGM1 T  cell clones to form dense 
aggregates with B cells in IgE-producing cultures. Contact 
between T  and B cells is obligate for IgE induction (2) and 
the above finding suggests that IgE-helper HIGM1 clones 
may express an important surface structure(s) that mediates 
and/or induces B cell contact.  Certainly, the induction of 
IgE using HIGM1 T cell clones was a contact-mediated event 
as separation of T and B cells by a semi-permeable membrane 
abrogated synthesis. 
We have shown that T cell clones, isolated from HIGM1 
PBMC can both induce IgE synthesis and secrete high levels 
of IL-4 in vitro, yet IgG, IgE, and IgA levels are barely de- 
tectable in vivo. This discrepancy suggests that the absence 
of CD40L has wider implications for aberrant immune func- 
tion in vivo in addition to an inability to synthesize switched 
Ig isotypes.  Indeed, CD40L is required for germinal center 
formation in humans (10) and mice (44) and rescues B cells 
from apoptosis (45). Also, CD40 provides a strong coactiva- 
tion stimulus to CD4 + T  cells, resulting in generation of 
CTL and selective expansion of CD4 + cells (46).  Recipro- 
cally, activated T  cells induce expression of B7/BB1  on B 
cells through a CD40-dependent signal (47).  The overall T 
cell repertoire in HIGM1 may also be abnormal as stimula- 
tion of CD40,  which is constitutively expressed on human 
thymic epithelial cells,  induces lymphokine secretion (48) 
which may in turn affect thymic function. Last, a direct effect 
of CD40L that could contribute to immunodeficiency may 
be an impaired bactericidal function of monocytes, since it 
has recently been shown that ligation of CD40 on mono- 
cytes with CD40L potentiates both cytokine production and 
tumoricidal activity (49). Taken together, the above findings 
show that T  cell clones and lines,  isolated from a HIGM1 
patient are able to induce IgE synthesis in vitro despite the 
absence of full-length, functional CD40L,  and suggest the 
existence of other T cell surface structures capable of inducing 
IgE switching. 
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